Broncho-alveolar lavage in patients with acute respiratory distress syndrome due to COVID-19.
Christian G CornelissenIngmar BergsAnnegret G MüllerAyham DaherAlexander KerstenPaul BalfanzSebastian LemmenGernot MarxNikolaus MarxMichael DreherTobias MüllerPublished in: Internal medicine journal (2021)
As data about microbiological testing and the cellular composition of the broncho-alveolar lavage (BAL) fluid in patients ventilated due to coronavirus disease 2019 (COVID-19) are lacking, this was investigated in a retrospective analysis (n = 58). Co-infection with pathogens was detected in 31 patients, whereas the analysis of BAL cellularity showed an increased total cell count and an alveolitis dominated by neutrophils. None of the physicians performing bronchoscopies in COVID-19 patients had serological evidence of severe acute respiratory syndrome coronavirus 2 infection.
Keyphrases
- coronavirus disease
- acute respiratory distress syndrome
- sars cov
- respiratory syndrome coronavirus
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- extracorporeal membrane oxygenation
- primary care
- prognostic factors
- intensive care unit
- stem cells
- mechanical ventilation
- electronic health record
- bone marrow
- cell therapy
- mesenchymal stem cells
- machine learning
- big data
- atomic force microscopy
- high resolution
- antimicrobial resistance